Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Korea, Democratic People's Republic of (North Korea) - Infant Mortality Rate for the Democratic People's Republic of Korea was 14.50000 Number per 1,000 Live Births in January of 2023, according to the United States Federal Reserve. Historically, Korea, Democratic People's Republic of (North Korea) - Infant Mortality Rate for the Democratic People's Republic of Korea reached a record high of 55.10000 in January of 1996 and a record low of 13.10000 in January of 2019. Trading Economics provides the current actual value, an historical data chart and related indicators for Korea, Democratic People's Republic of (North Korea) - Infant Mortality Rate for the Democratic People's Republic of Korea - last updated from the United States Federal Reserve on December of 2025.
Facebook
TwitterIn 2024, the number of births in South Korea stood at *******, a slight increase compared to the previous year. Around two decades earlier, this number was twice as high. Declining fertility in South Korea A phenomenon that most East Asian countries and territories grapple with is a stark decline in fertility rates. This is especially evident in South Korea, which has the lowest fertility rate in the world, far below the 2.1 children per woman threshold that represents replacement fertility. In response to the expected economic consequences of a declining population, South Korea has implemented various initiatives to encourage married couples to have children. Factors contributing to low birth rates in South Korea One major element is the societal change in attitudes toward childbirth. In a survey, half of the South Korean respondents asserted that marriages can be happy without children, and a sizable share also stated that having children was dependent on economic factors. In addition, an increasing number of South Koreans are choosing not to get married. In 2023, South Korea recorded one of the lowest numbers of marriages in its history. Furthermore, there has been a growing trend among South Korean women to prioritize their financial independence and career continuity over traditional expectations of childbearing.
Facebook
TwitterIt is a small dataset but I wanted to check what kind of reality mother faces when having a child. It would be nice if I can compare the data with other countries, but I only got South Korea data :(. If anyone has similar dataset that I can compare with, it would be interesting to work on together!
Being a mother is definitely a bless and something to be celebrated, but it is also evident that there are lots of things to give up for child. I believe biggest risk that mother sacrifices most is their 'career.'
South Korea is well known for extremely low annual birth rate. According to recent statistics, 0.92 child are born per woman (2019). Low annual birth rate implies how hostile social environment is to have child and make family. Politicians are coming up with new support policies to improve low birth rate issue, but still it's not working well.
Hope South Korea become a bright society where mothers can pursue their career!
Data Description Minus days : before birth Plus days : after birth Birth : Birth date
Source Source: dataset from Korea Statistical Information Service(https://kosis.kr/index/index.do)
Facebook
TwitterThe statistic shows the total population of South Korea from 1980 to 2024, with projections up until 2030. In 2024, the total population of South Korea was about 51.75 million people. Population of South Korea South Korea, also called Republic of Korea, has one of the highest population densities worldwide, i.e. a very high number of inhabitants per square kilometer. However, this does not equal bad standard of living; on the Human Development Index, which ranks countries by their level of living standards using key factors, such as unemployment rate, literacy rate, fertility and mortality rates, etc., South Korea is among the highest-ranked countries. When looking at the aforementioned key factors, South Korea indeed seems to offer a fairly stable environment for its inhabitants, economically and demographically: The country’s unemployment rate has been relatively steady for the past decade, its gross domestic product (GDP) is constantly increasing, and it is among the countries with the highest trade surplus worldwide. As for standard of living, life expectancy at birth in South Korea is among the highest worldwide – South Korea is even mentioned in a recent ranking of the best birthplaces for children. Despite the high population density, South Korea is now one of the countries with the lowest fertility rates, i.e. the number of babies born by women of childbearing age. This apparent discrepancy could be explained by a high number of immigrants coupled with the aforementioned high life expectancy.
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
BackgroundNon-pharmaceutical interventions (NPIs), such as social distancing and hand washing, have been associated with a decline in the preterm birth rate worldwide. We aimed to evaluate whether the preterm birth rate in Korea during the coronavirus disease 2019 lockdown has changed compared to that in previous years.MethodA birth registry from the Korea Statistical Information Service, which is a nationwide official database, was used to include all births claimed to have occurred between 2011 and 2020. Newborns with gestational age (GA) less than 22 weeks and birth weight less than 220 g were excluded. The pre-NPI period was designated as January 2011 to January 2020, and the NPI period was defined as February 2020 to December 2020. We assessed the effect of NPI on the incidence of prematurity per 100 births using an interrupted time-series quasi-experimental design and implementing an autoregressive integrated moving average (ARIMA) model.ResultsFrom 2011 to 2020, a total of 3,931,974 live births were registered, among which 11,416 were excluded. Consequently, the final study population included 3,920,558 live births (both singleton and multiple births) among which 275,009 (7.0%) were preterm. The preterm birth rate was significantly higher during the NPI period (8.68%) compared to that in the pre-NPI period (6.92%) (P
Facebook
TwitterIntroductionChildren who have experienced the coronavirus disease 2019 (COVID-19) pandemic are at an increased risk of adverse neurologic developmental outcomes. Limited data exist on the environmental influences of during the COVID-19 pandemic on preterm infant development. This study aimed to investigate whether COVID-19 exposure affects the neurodevelopmental outcomes in preterm children up to 3 years of age.MethodsThis prospective cohort study included all very low birth weight (VLBW) infants from the Korean Neonatal Network who had undergone a neurodevelopmental assessment between January 2015, and May 2022. The neurodevelopmental outcomes along with the scores on the Bayley Scales of Infant and Toddler Development (BSID) and the Korean Developmental Screening Test for Infants and Children of pediatric patients aged 18–24 and 33–39 months who were exposed to COVID-19 were compared with those of VLBW children born and tested before the pandemic.ResultsThe cohort included 1,683 VLBW infants. The pandemic group had significantly lower language scores on the BSID-III at ages 18–24 months (p = 0.021) and 33–39 months (p = 0.023) than the pre-pandemic group after adjusting for gestational age, morbidity, and environmental factors. At 2nd follow-up period, the pandemic group showed significantly lower scores in the cognitive (p = 0.026) domains with a mean difference of 7 points and had a significantly higher percentage of ≤−1SD in the gross motor domain (p < 0.001) compared with the pre-pandemic group.ConclusionPreterm children who experienced the COVID-19 pandemic are at higher risk of abnormal neurodevelopmental outcomes in the first 3 years of life than preterm infants born before the COVID-19 pandemic.
Facebook
Twitterhttps://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
| BASE YEAR | 2024 |
| HISTORICAL DATA | 2019 - 2023 |
| REGIONS COVERED | North America, Europe, APAC, South America, MEA |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| MARKET SIZE 2024 | 2,000(USD Million) |
| MARKET SIZE 2025 | 2,100(USD Million) |
| MARKET SIZE 2035 | 3,800(USD Million) |
| SEGMENTS COVERED | Application, Product Type, End Use, Technology, Regional |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
| KEY MARKET DYNAMICS | Increasing neonatal mortality rates, Advancements in medical technology, Growing government healthcare initiatives, Rising awareness of neonatal care, Expansion of healthcare infrastructure |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Crucial Air, Hawkeye Medical, Smiths Medical, Philips, Stryker, Welch Allyn, Becton Dickinson, Dräger, Medtronic, GE Healthcare, Nellcor, Fisher & Paykel Healthcare |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| KEY MARKET OPPORTUNITIES | Technological advancements in devices, Increasing demand in emerging markets, Growing awareness for neonatal health, Expansion of healthcare infrastructure, Rising collaboration among key players |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.0% (2025 - 2035) |
Facebook
Twitterhttps://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
| BASE YEAR | 2024 |
| HISTORICAL DATA | 2019 - 2023 |
| REGIONS COVERED | North America, Europe, APAC, South America, MEA |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| MARKET SIZE 2024 | 1331.9(USD Million) |
| MARKET SIZE 2025 | 1410.5(USD Million) |
| MARKET SIZE 2035 | 2500.0(USD Million) |
| SEGMENTS COVERED | Product Type, Application, End User, Technology, Regional |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
| KEY MARKET DYNAMICS | Rising neonatal mortality rates, Advancements in technology, Increasing healthcare expenditure, Growing awareness of infant care, Demand for home healthcare solutions |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Drägerwerk, Getinge, Fisher & Paykel Healthcare, SLE Limited, Kangaroo, Mediware, Philips Healthcare, Apollo Health and Beauty Care, Medtronic, Chirana T. Injecta, Natus Medical, MediQUIP, Masimo, Vyaire Medical, GE Healthcare |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| KEY MARKET OPPORTUNITIES | Technological advancements in devices, Rising neonatal care awareness, Increased prevalence of preterm births, Expansion into emerging markets, Government healthcare initiatives funding |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.9% (2025 - 2035) |
Facebook
Twitterhttps://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
| BASE YEAR | 2024 |
| HISTORICAL DATA | 2019 - 2023 |
| REGIONS COVERED | North America, Europe, APAC, South America, MEA |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| MARKET SIZE 2024 | 16.1(USD Billion) |
| MARKET SIZE 2025 | 16.8(USD Billion) |
| MARKET SIZE 2035 | 25.0(USD Billion) |
| SEGMENTS COVERED | Product Type, End User, Application, Distribution Channel, Regional |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
| KEY MARKET DYNAMICS | Increasing birth rates, Technological advancements, Rising maternal health awareness, Government initiatives, Growing healthcare expenditure |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Dräger, General Electric, Medtronic, Natus Medical, Johnson & Johnson, Philips, Honeywell, Siemens Healthineers, Masimo, Fisher & Paykel Healthcare, Stryker, Becton Dickinson |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| KEY MARKET OPPORTUNITIES | Innovative product development, Rising global birth rates, Increasing healthcare investments, Expansion in telemedicine services, Growing demand for eco-friendly products |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.1% (2025 - 2035) |
Facebook
TwitterAs of 2023, the countries with the highest life expectancy included Switzerland, Japan, and Spain. As of that time, a new-born child in Switzerland could expect to live an average of **** years. Around the world, females consistently have a higher average life expectancy than males, with females in Europe expected to live an average of *** years longer than males on this continent. Increases in life expectancy The overall average life expectancy in OECD countries increased by **** years from 1970 to 2019. The countries that saw the largest increases included Turkey, India, and South Korea. The life expectancy at birth in Turkey increased an astonishing 24.4 years over this period. The countries with the lowest life expectancy worldwide as of 2022 were Chad, Lesotho, and Nigeria, where a newborn could be expected to live an average of ** years. Life expectancy in the U.S. The life expectancy in the United States was ***** years as of 2023. Shockingly, the life expectancy in the United States has decreased in recent years, while it continues to increase in other similarly developed countries. The COVID-19 pandemic and increasing rates of suicide and drug overdose deaths from the opioid epidemic have been cited as reasons for this decrease.
Facebook
Twitterhttps://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
| BASE YEAR | 2024 |
| HISTORICAL DATA | 2019 - 2023 |
| REGIONS COVERED | North America, Europe, APAC, South America, MEA |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| MARKET SIZE 2024 | 6.1(USD Billion) |
| MARKET SIZE 2025 | 6.4(USD Billion) |
| MARKET SIZE 2035 | 10.2(USD Billion) |
| SEGMENTS COVERED | Product Type, Distribution Channel, End User, Infant Age Group, Regional |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
| KEY MARKET DYNAMICS | rising birth rates, increasing healthcare expenditure, growing awareness of infant care, advancements in medical technology, demand for quality healthcare services |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Nestlé, Mead Johnson Nutrition, Philips, KimberlyClark, Becton Dickinson, Abbott Laboratories, Medtronic, Pampers, Natus Medical, Hollister, Drägerwerk, Johnson & Johnson, GE Healthcare, Siemens Healthineers, Fisher & Paykel Healthcare |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| KEY MARKET OPPORTUNITIES | Rising birth rates globally, Increasing disposable income, Growing awareness of infant health, Technological advancements in care, Expanding e-commerce for baby products |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.8% (2025 - 2035) |
Facebook
Twitterhttps://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
| BASE YEAR | 2024 |
| HISTORICAL DATA | 2019 - 2023 |
| REGIONS COVERED | North America, Europe, APAC, South America, MEA |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| MARKET SIZE 2024 | 2113.7(USD Million) |
| MARKET SIZE 2025 | 2263.7(USD Million) |
| MARKET SIZE 2035 | 4500.0(USD Million) |
| SEGMENTS COVERED | Service Type, Client Demographics, Pricing Model, Geographical Coverage, Regional |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
| KEY MARKET DYNAMICS | Increasing demand for personalized care, Rising awareness of midwifery benefits, Growing focus on maternal health, Shift towards home births, Enhanced government support for midwives |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Midwifery Matters, Calm Birth, Gentle Birth, Supporting Midwifery, Natural Beginnings, Mamadou Midwives, The Motherhood Group, The Midwife Company, Nurturing Birth, The Midwives Alliance, Acuity Midwifery, Birth Collective, Boram Midwifery, Midwifery Group, Your Baby Midwife |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| KEY MARKET OPPORTUNITIES | Increased demand for personalized care, Rising maternal health awareness, Growth of telehealth services, Expansion into underserved regions, Integration with holistic health practices |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.1% (2025 - 2035) |
Facebook
TwitterWith an average of *** births per woman, Afghanistan had the highest fertility rate throughout the Asia-Pacific region in 2025. Pakistan and Papua New Guinea followed with the second- and third-highest fertility rates, respectively. In contrast, South Korea and Macao had the lowest fertility rates across the region. Contraception usage Fertility rates among women in the Asia-Pacific region have fallen throughout recent years. A likely reason is an increase in contraception use. However, contraception usage varies greatly throughout the Asia-Pacific region. Although contraception prevalence is set to increase across South Asia by 2030, women in both East Asia and Southeast Asia had higher contraception usage compared to South Asia in 2019. Women in APAC With the rise of feminism and the advancement of human rights, attitudes towards the role of women have changed in the Asia-Pacific region. Achieving gender equality has become a vital necessity for both men and women throughout the region. Alongside changes in traditional gender roles, women in certain Asia-Pacific countries, such as New Zealand, have become more inclined to marry later in life. Furthermore, the focus for younger women appears to be on having stability in their lives and securing an enjoyable job. This was displayed when female high school students in Japan were questioned about their future life aspirations.
Facebook
TwitterIn 2023, the average age of mothers giving birth to their first child in South Korea was ***** years. The average age at childbirth in South Korea has risen steadily over the last decades.
Facebook
TwitterIn 2023, the number of male births per 100 female births in South Korea was *****. The sex ratio at birth has declined overall in South Korea over the last decades.
Facebook
TwitterOver the last two observations, the life expectancy has significantly increased in all gender groups Comparing the two different gender groups for the year 2023, the 'life expectancy of women at birth' leads the ranking with 80.52 years. Contrastingly, 'life expectancy of men at birth' is ranked last, with 75.67 years. Their difference, compared to life expectancy of women at birth, lies at 4.85 years. Life expectancy at birth refers to the number of years the average newborn is expected to live, providing that mortality patterns at the time of birth do not change thereafter.Find further similar statistics for other countries or regions like North Korea and France.
Facebook
TwitterAmong all countries that are part of the Organization for Economic Co-operation and Development (OECD), Turkey, followed by Korea, had the highest rate of Caesarean section births (or C-sections) in 2022. At that time, the rate of C-sections in Turkey was roughly 600 per 1,000 live births. Among global regions, Latin America and the Caribbean had the highest percentage of births that were delivered by C-section, while sub-Saharan Africa had the lowest rates of Cesarean section births. Cesarean section costs A Cesarean section is a form of birth where the baby is taken out through a surgical incision in the abdomen rather than a natural vaginal birth. The cost of a Cesarean section delivery varies globally, with the United States having the highest cost globally for Cesarean section deliveries, while Germany the lowest cost among selected countries worldwide. In the United States, C-sections are significantly more expensive than a delivery by vaginal birth. High C-sections rates in the U.S. Over the past 20 years the C-section rate in the U.S. has gradually been increasing with more stable trends in the past few years. It has been reported that many of the C-sections performed in the U.S. are elective and not necessary. Often, the risks of C-sections are greater than the benefits, when performed as an elective procedure. Therefore, the United States has a "healthy people target" for the c-section rate of first time, low-risk mothers. However, less than half of hospitals are meeting the national targets for Cesarean sections performed.
Facebook
TwitterMonaco had the highest life expectancy among both men and women worldwide as of 2024. That year, life expectancy for men and women was ** and ** years, respectively. The East Asian countries and regions, Hong Kong, Japan, South Korea, and Macao, followed. Many of the countries on the list are struggling with aging populations and a declining workforce as more people enter retirement age compared to people entering employment.
Facebook
Twitterhttps://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
| BASE YEAR | 2024 |
| HISTORICAL DATA | 2019 - 2023 |
| REGIONS COVERED | North America, Europe, APAC, South America, MEA |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| MARKET SIZE 2024 | 2,000(USD Million) |
| MARKET SIZE 2025 | 2,200(USD Million) |
| MARKET SIZE 2035 | 4,000(USD Million) |
| SEGMENTS COVERED | Product Type, Nutritional Composition, Distribution Channel, End User, Regional |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
| KEY MARKET DYNAMICS | regulatory compliance, increasing preterm birth rates, rising awareness about nutrition, technological advancements in formulation, expanding healthcare infrastructure |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Mead Johnson Nutrition, Hero Group, Kendall Nutrition, Abbott Laboratories, Fresenius Kabi, Arla Foods, Danone, BASF, H.J. Heinz Company, Milupa, Nutricia, MediGrove, Nestle, Perrigo Company, Ebm Medical |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| KEY MARKET OPPORTUNITIES | Rising preterm birth rates, Increasing parental awareness, Growing demand for specialized nutrition, Advances in nutritional formulations, Expansion in emerging markets |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.3% (2025 - 2035) |
Facebook
Twitterhttps://www.wiseguyreports.com/pages/privacy-policyhttps://www.wiseguyreports.com/pages/privacy-policy
| BASE YEAR | 2024 |
| HISTORICAL DATA | 2019 - 2023 |
| REGIONS COVERED | North America, Europe, APAC, South America, MEA |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| MARKET SIZE 2024 | 2.48(USD Billion) |
| MARKET SIZE 2025 | 2.64(USD Billion) |
| MARKET SIZE 2035 | 5.0(USD Billion) |
| SEGMENTS COVERED | Treatment Method, Patient Type, End User, Drug Class, Regional |
| COUNTRIES COVERED | US, Canada, Germany, UK, France, Russia, Italy, Spain, Rest of Europe, China, India, Japan, South Korea, Malaysia, Thailand, Indonesia, Rest of APAC, Brazil, Mexico, Argentina, Rest of South America, GCC, South Africa, Rest of MEA |
| KEY MARKET DYNAMICS | rising prevalence of preterm births, increasing awareness about pregnancy complications, advancements in prenatal care technologies, government initiatives and funding, development of personalized medicine approaches |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | AstraZeneca, Boehringer Ingelheim, Merck & Co, GSK, Medscape, AbbVie, Eli Lilly and Company, Sanofi, Amgen, Ferring Pharmaceuticals, Johnson & Johnson, Pfizer, Novartis, Teva Pharmaceutical Industries, Bayer, HoffmannLa Roche |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| KEY MARKET OPPORTUNITIES | Innovative pharmaceutical developments, Increased awareness programs, Enhancements in prenatal care, Growing demand for personalized treatments, Strategic partnerships with healthcare institutions |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.6% (2025 - 2035) |
Facebook
TwitterAttribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Korea, Democratic People's Republic of (North Korea) - Infant Mortality Rate for the Democratic People's Republic of Korea was 14.50000 Number per 1,000 Live Births in January of 2023, according to the United States Federal Reserve. Historically, Korea, Democratic People's Republic of (North Korea) - Infant Mortality Rate for the Democratic People's Republic of Korea reached a record high of 55.10000 in January of 1996 and a record low of 13.10000 in January of 2019. Trading Economics provides the current actual value, an historical data chart and related indicators for Korea, Democratic People's Republic of (North Korea) - Infant Mortality Rate for the Democratic People's Republic of Korea - last updated from the United States Federal Reserve on December of 2025.